TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
CGNX

Cognex Corporation

Technology · Scientific & Technical Instruments

62.00$ +0.7% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Cash Flow

Cognex Corporation (CGNX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at 246 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow CGNX
Line item 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
51 53 30 55 76 21 16 31 63 43 48 48 59 12 76 86 101 95 156 118 182 224 223 253 242 314 243 113 149 246
5.1 5.8 8.7 9.3 12 14 9.5 10 10.0 11 12 11 11 9.6 9.8 9.8 11 11 12 14 15 17 22 25 27 20 20 22 33 31
5.8 12 4.2 8.9 31 7.6 12 10 9.2 3.0 8.1 8.5 11 15 20 21 32 41 46 43 44 55 55 52 49
1.6 8.6 3.6 3.6 3.7 5.6 4.3 -71 17 33 40 -52 56 40 27
9.3 -1.5 0.6 13 -26 -5.2 3.1 -0.1 6.5 -9.4 -15 5.4 3.6 -10 -1.7 -3.5 13 2.7 16 -13 0.1 -3.4 -58 77 -31 -34 -74 -68 -25 1.7
10 11 7.2 3.4 7.8 4.5 2.2 2.5 3.1 3.8 4.2 4.6 6.0 5.5 5.9 7.8 9.9 13 21 29 13 29 37 22 13 15 20 23 15 8.7
-29 -68 -3.6 -47 -99 -38 39 -30 -92 -21 53 8.7 65 -0.5 -176 -90 -39 -88 -104 -11 -122 -106 -11 -157 169 -253 -4.5 32 -39 28
5.2 13 15 15 15 19 12 10 15 66 0.0 18 18 25 29 32 35 391 43 46 49 52 55
-40 4.6 -26 -12 -86 -33 -93 0.1 28 -10 17 -48 -60 -126 -47 -124 -204 -62 -51 -162 -204 -80 -67 -151
2.5 5.0 -36 14 18 4.6 -21 15 31 0.6 -90 -41 -96 -21 20 9.8 -45 -12 -35 -107 -29 -100 -210 -32 -317 -142 -240 -126 -118 -207
25 -10 -10 21 -5.7 -11 29 15 4.3 19 15 17 23 -7.3 -87 4.9 7.1 -4.5 15 -3.7 28 27 1.6 63 98 -83 -4.8 21 -17 77
41 42 23 52 69 16 14 29 60 39 44 44 53 6.8 70 78 91 82 135 90 169 196 186 231 229 299 224 90 134 237

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?